Expression levels of estrogen receptor (ER) gene and three ER-related genes in metastatic ER-positive breast cancer compared with response to endocrine therapy.

被引：0

作者：

Lai, S ^{[1
]}

Valero, V ^{[1
]}

Booster, D ^{[1
]}

Fiterman, DJ ^{[1
]}

Pusztai, L ^{[1
]}

Symmans, WF ^{[1
]}

机构：

[1] UT MD Anderson Canc Ctr, Houston, TX USA

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S60 / S60

页数：1

共 50 条

[31] Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer:: Specific correlation with progesterone receptor [J].

Saji, S ;

Omoto, Y ;

Shimizu, C ;

Warner, M ;

Hayashi, Y ;

Horiguchi, S ;

Watanabe, T ;

Hayashi, S ;

Gustafsson, JÅ ;

Toi, M .

CANCER RESEARCH, 2002, 62 (17) :4849-4853

[32] Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients [J].

Nasr M. A. Allahloubi ;

Abdel-Rahman N. Zekri ;

Mohamed Ragab ;

Marwa Mohanad ;

Ola S. Ahmed ;

Salem Eid ;

Mohamed Ghareeb ;

Iman Gouda ;

Abeer A. Bahnassy .

Biochemical Genetics, 2022, 60 :1963-1985

[33] HOXB13 is an estrogen receptor responsive gene preferentially methylated in ER-positive breast cancer [J].

Rodriguez, Benjamin A. T. ;

Jin, Victor X. ;

Cheng, Alfred S. ;

Davuluri, Ramana V. ;

Gray, Joe W. ;

Huang, Tim H-M .

CANCER RESEARCH, 2006, 66 (08)

[34] Primary endocrine therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients [J].

不详 .

EJC SUPPLEMENTS, 2006, 4 (02) :117-117

[35] ER and PI3K Independently Modulate Endocrine Resistance in ER-Positive Breast Cancer [J].

Van Tine, Brian A. ;

Crowder, Robert J. ;

Ellis, Matthew J. .

CANCER DISCOVERY, 2011, 1 (04) :287-288

[36] Neoadjuvant endocrine therapy vs chemotherapy for postmenopausal ER-positive breast cancer patients [J].

Semiglazov, VF ;

Ivanov, VG ;

Semiglazov, VV ;

Ziltsova, EK ;

Keltzel, AA ;

Melnikova, OA ;

Topuzov, EE ;

Paltuev, RM ;

Bozhok, AA ;

Dashian, GA .

BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 :S106-S107

[37] Effective sequence of endocrine therapy for ER-positive and HER2-negative metastatic breast cancer. [J].

Osako, Tomofumi ;

Nishimura, Reiki ;

Nishiyama, Yasuyuki ;

Tashima, Rumiko ;

Fujisue, Mamiko ;

Nakano, Masahiro ;

Toyozumi, Yasuo ;

Arima, Nobuyuki .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[38] Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age [J].

Sandra M. Swain ;

Raquel Nunes ;

Carl Yoshizawa ;

Megan Rothney ;

Amy P. Sing .

Advances in Therapy, 2015, 32 :1222-1236

[39] Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age [J].

Swain, Sandra M. ;

Nunes, Raquel ;

Yoshizawa, Carl ;

Rothney, Megan ;

Sing, Amy P. .

ADVANCES IN THERAPY, 2015, 32 (12) :1222-1236

[40] Evolution of genomic alterations on endocrine therapy and mTOR inhibition in estrogen receptor (ER)-positive breast cancer [J].

Massarweh, S. ;

Romond, E. ;

Stewart, R. ;

Sun, J. ;

Chmielecki, J. ;

Mehdi, M. ;

Black, E. P. .

CANCER RESEARCH, 2016, 76

← 1 2 3 4 5 →